Issues
-
Cover Image
Cover Image
DNA damage elicits a cellular program of damage control coordinated by the kinase activity of ATM. Kirshner et al. show that ATM activity, but not abundance, is severely compromised in murine cells in which the Tgfβ1 gene is deleted and in human epithelial cells in which TGFβ signaling is blocked. This defect is evident by the absence of γH2AX foci at 30 min after exposure to ionizing radiation (2 Gy) in Tgfβ1-null compared to Tgfβ1-heterozygote keratinocytes, as detected by γH2AX immunofluorescence (green) in DAPI-stained nuclei (blue). As a consequence of the failure of ATM to phosphorylate its substrates, inhibiting TGFβ signaling compromises radiation-induced apoptosis and cell-cycle arrest and increases cell kill as measured by clonogenic assay. These data demonstrate a previously unsuspected role for extracellular signaling in the genotoxic stress program of epithelial cells, and contributes a new and important action for TGFβ1 as a tumor suppressor. Future studies to identify the molecular mechanism of ATM kinase inhibition in epithelial cells may support the use of TGFβ inhibitors to increase response to radiotherapy. For details, see the article by Kirshner et al. on page 10861 of this issue. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Reviews
Meeting Report
Priority Reports
Molecular Biology, Pathobiology, and Genetics
Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion
Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13-Acetate–Induced Death by Attenuating Activating Transcription Factor 3 Induction
Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications
Cell, Tumor, and Stem Cell Biology
A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
Reassessment of Id1 Protein Expression in Human Mammary, Prostate, and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Id1 Antibody
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring
Immunology
CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells
Functional CXCR4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells
Endocrinology
Clinical Research
Molecular Imaging of Proliferation in Malignant Lymphoma
Epidemiology and Prevention
DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer
Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.